SCHEMBL4163229

SCHEMBL4163229

CCNN.NCCOC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTH P32929 1/20 0.37
LMNA P02545 1/20 0.36
ALOX15 P16050 2/20 0.34
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
CNR1 P21554 1/20 0.33
CYP1A2 P05177 1/20 0.33
IDO1 P14902 1/20 0.33
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
RAB9A P51151 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1263484 0.83
Bicarbonate SCHEMBL28648202 0.81 CTH (0.40) CTHLMNAALOX15MAPTALDH1A1
Ammonia Solution, Strong SCHEMBL20920090 0.81
Hydrochloric Acid SCHEMBL28664938 0.81
Bicarbonate SCHEMBL31492006 0.72
SCHEMBL910612 0.71 TSHR (0.39) CTHLMNAMAPTALDH1A1THRB
SCHEMBL20099472 0.71
SCHEMBL27663332 0.71
Oxalic Acid SCHEMBL55207 0.70 ALOX15 (0.59) ALOX15ALDH1A1CYP1A2GAA
Acetic Acid SCHEMBL4492710 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846422-B1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO LTD (KR) 2016-04-13 EP claimed
EP-2995620-B1 ORGANIC SILVER COMPLEX, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYRERS INKTEC CO LTD (KR) 2018-09-19 EP disclosed
US-9914743-B2 Organic silver complexes, their preparation methods and their methods for forming thin layers INKTEC CO., LTD. (KR) 2018-03-13 US disclosed
US-20160194339-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers INKTEC CO., LTD. (KR) 2016-07-07 US disclosed
EP-1846422-B1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO LTD (KR) 2016-04-13 EP disclosed
EP-2995620-A1 ORGANIC SILVER COMPLEX, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYRERS Inktec Co., Ltd. (KR) 2016-03-16 EP disclosed
US-20140179944-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers INKTEC CO., LTD. (KR) 2014-06-26 US disclosed
US-8679242-B2 Organic silver complexes, their preparation methods and their methods for forming thin layers INKTEC CO., LTD. (KR) 2014-03-25 US disclosed
US-20130022761-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers INKTEC CO., LTD. (KR) 2013-01-24 US disclosed
US-8226755-B2 Organic silver complexes, their preparation methods and their methods for forming thin layers INKTEC CO., LTD. (KR) 2012-07-24 US disclosed
US-20090120800-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers INKTEC CO., LTD. (KR) 2009-05-14 US disclosed
EP-1846422-A1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS Inktec Co., Ltd. (KR) 2007-10-24 EP disclosed
WO-2006083153-A1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO., LTD. (KR) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090120800-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers CA3, C9, CLTC CTH 1306/4885LMNA 2694/4885ALOX15 3948/4885
US-20140179944-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers C9, CA3, C5 CTH 1857/4885LMNA 2781/4885ALOX15 4654/4885
US-20160194339-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers AGPS, DNMT1, TUBA3C CTH 1957/4885LMNA 1935/4885ALOX15 4327/4885
US-20130022761-A1 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers CA3, C9, CLTC CTH 1306/4885LMNA 2694/4885ALOX15 3948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.